Good MorningThe equities market ended a down week on a sour note with the major indices flat to slightly down on Friday. Traders are wary of new developments in the earnings outlook that suggests 2020’s robust rebound will slow in 2021.
The detail investors need to stay focused on is that revenue and earnings growth will continue for the S&P 500 in 2021 whether or not growth accelerates. Looking at the market from that perspective, price weakness in the major indices will most likely lead to gains in the 2nd half of the year.
This week the market will be focused on economic data. There are a dozen major reports due out over the week including the Leading Indicators, Consumer Spending, Personal Income, and Pending Home Sales and any could be the trigger for a market sell-off. If one comes, be ready with some cash to scoop up the deals.
Featured: Man Who Predicted March 2020 Crash Makes Bold Tech Stock Prediction (Legacy Research) 
|
Stocks | | | Combine that with the fact that President Joe Biden has big infrastructure plans and it’s safe to say that industrial stocks are worth a look at this time. Here are 3 industrial stocks to buy that are showing relative strength. Read the Full Story |
|
|
Markets | | |
Shares of Palantir (NYSE:PLTR) stock got a big lift on February 19, 2021. First, the company got upgraded by Goldman Sachs (NYSE:GS) analyst Christopher Merwin. The analyst raised PLTR stock from neutral to buy with an accompanying price target of $34 (previously $13). Bullish investors also cheer... Read the Full Story |
|
Politics | | | It seemed like a match made in finance heaven.
In 2010, China, its economy roaring and state companies looking to expand globally, set its eyes on Latin America, a region starved of capital but rich in natural resources the Asian giant lacked. The result: a record $35 billion in stat... Read the Full Story |
|
|
Tech | | | In spite of the surging coronavirus pandemic, major arms makers descended Sunday on a convention center in Abu Dhabi, the capital of the United Arab Emirates, hoping to make deals with militaries across the Middle East.
The UAE unveiled $1.36 billion in local and foreign arms deals to... Read the Full Story |
|
Markets | | |
It’s setting up to be another strong quarter for The Home Depot (NYSE:HD). The home improvement retailer is expecting to report earnings per share of $2.61 on revenue of $30.45 billion. And the whisper number suggests that the company’s EPS may be even higher ($2.74).
Sequentially, th... Read the Full Story |
|
From Our PartnersAs demand comes back swinging, oil will be well worth watching this year. With a focus on what could be the biggest shale play in the U.S., this company may be about to capture Wall Street's attention | | | | Continue Reading |
|
Politics | | | Global shares were mostly lower on Monday, with Japan's benchmark rising but most others slipping despite hopes for a recovery from the coronavirus pandemic with the global rollout of vaccines.
France's CAC 40 slipped 1.1% in early trading to 5,708.39, while Germany's DAX dove 1.3% t... Read the Full Story |
|
Politics | | | Two days before the storm began, Houston’s chief elected official warned her constituents to prepare as they would for a major hurricane. Many took heed: Texans who could stocked up on food and water, while nonprofits and government agencies set out to help those who couldn’t.
But few... Read the Full Story |
|
Stocks | | |
One of the biggest stories that investors should be monitoring right now is the unprecedented shortage of semiconductors. The shortage is directly related to the pandemic and how it has affected the supply chains for these chips that are used in everything from video game consoles to automobiles. ... Read the Full Story |
|
Politics | | | LONDON — Researchers in Scotland say its COVID-19 vaccination program has led to a sharp drop in hospitalizations.
Scientists from the University of Edinburgh, the University of Strathclyde and Public Health Scotland found that the Pfizer vaccine reduced hospital admissions by as much... Read the Full Story |
|
Markets | | | Walmart (NYSE: WMT) reported its Q4 2021 earnings (the period ending December 31, 2020) and investors did not like the results; shares cratered by more than 6% on the news. That’s a big move for any company, but we’re not talking about some volatile tech stock here – Walmart is a l... Read the Full Story |
|
The Early Bird Stock Of The Day Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. It also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG was incorporated in 1996 and is headquartered in Bad Homburg, Germany. | | View Today's Stock Pick |
|
